FDA’s plan to ban hair relaxer chemical called too little, too late

In April, a dozen years after a federal agency classified formaldehyde a human carcinogen, the Food and Drug Administration is tentatively scheduled to unveil a proposal to consider banning the chemical in hair-straightening products.

Bruker to buy cell biology company PhenomeX for $108m

PhenomeX offers single-cell biology research tools for delivering insights into cellular function. Credit: Arek Socha from Pixabay. Bruker has entered a definitive agreement to acquire

August 18, 2023

Shorter Antibiotic Course Noninferior for UTI Recurrence in Kids

Five days of oral antibiotic treatment for febrile urinary tract infections (UTIs) in kids was noninferior to the standard 10-day course, the randomized controlled STOP

December 27, 2023

The impact of AI and ChatGPT on health data – Pharmaceutical Technology

In the healthcare industry, AI is unlocking new possibilities and solving grand healthcare challenges by improving care outcomes, life science innovation, and patient experience in

July 18, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.